Management of ventral hernia after giant exomphalos with external pressure compression using helmet device.
OBJECTIVE
The aim of this study was to evaluate an alternative technique of reducing a ventral hernia that follows the primary conservative treatment of a giant omphalocoele.


METHODS
The patient is a full-term male neonate with a giant exomphalos. Initially triple dye was applied as an eschar-inducing agent. This resulted in a ventral hernia after 1 month. It was decided to achieve expansion of the abdominal cavity based on the principle of external pressure compression using a sphygmomanometer cuff over the hernia. The cuff was worn continuously, and manual pressure was applied daily. Care was taken to avoid intraabdominal hypertension using the reading of the manometer that was attached. The external pressure was corroborated with observations of respiration and circulation.


RESULTS
The child did not show any ill effects of raised intraabdominal pressure. Throughout the treatment, the child was on full oral feedings and did not require any ventilator support. Reduction of the ventral hernia was achieved in 9 months. Surgical repair of the residual hernia defect was carried out by double breasting of the fascia.


CONCLUSIONS
The application of controlled external pressure using a specially constructed device is a safe, noninvasive, and effective method of achieving reduction of a ventral hernia after primary conservative treatment of a giant omphalocoele.
Mali
V P
VP
Department of Paediatric Surgery, National University Hospital, Singapore.
Prabhakaran
K
K
Patankar
J Z
JZ
D001458:Bandages; D004338:Drug Combinations; D004867:Equipment Design; D005500:Follow-Up Studies; D005840:Gentian Violet / Q000627:therapeutic use; D006554:Hernia, Umbilical / Q000188:drug therapy* / Q000601:surgery; D006555:Hernia, Ventral / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011312:Pressure; D011370:Proflavine / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D019722:Sphygmomanometers
D004338:Drug Combinations; D000644:Quaternary Ammonium Compounds; C014234:Triple Dye; D011370:Proflavine; D005840:Gentian Violet